Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Yaman Tarabishy"'
Autor:
Marcus Messmer, Sunita Upreti, Yaman Tarabishy, Nikhilesh Mazumder, Reezwana Chowdhury, Mark Yarchoan, Matthias Holdhoff
Publikováno v:
Case Reports in Oncology, Vol 9, Iss 3, Pp 705-713 (2016)
Introduction: Ipilimumab is an immune checkpoint inhibitor targeting cytotoxic T-lymphocyte associated antigen 4 (CTLA4), approved to treat metastatic melanoma. It was the first therapy shown to prolong survival in a large, randomized clinical trial.
Externí odkaz:
https://doaj.org/article/247fbc43269f45c6b312208e82b421a7
Publikováno v:
Pathology. 54(6)
The significance of portal tract histological changes in non-alcoholic fatty liver disease (NAFLD) remains unclear. In 2019, CymaBay Therapeutics halted clinical trials of seladelpar (a PPARδ agonist) because initial end-of-treatment liver biopsies
Publikováno v:
Gastroenterology Research
Background Colorectal serrated polyps (SP), which include hyperplastic polyps (HP), sessile serrated adenomas/polyps (SSA/P), and traditional serrated adenomas, are not uncommon and have been implicated to play a role in the pathogenesis in a subset
Autor:
Yaman Tarabishy, Elizabeth A. Montgomery, Kevin M. Waters, Maryam Kherad Pezhouh, Marcia I. Canto, Kevan J. Salimian, Lysandra Voltaggio, Eun Ji Shin, Ogechukwu Eze
Publikováno v:
American Journal of Surgical Pathology. 42:264-268
Barrett esophagus (BE) predisposes patients to the development of esophageal adenocarcinoma (EAC). However, the global definition of BE is controversial. Pathologists in Europe and the United States require intestinal metaplasia (IM) within columnar-
Autor:
Sunita Upreti, Mark Yarchoan, Yaman Tarabishy, Reezwana Chowdhury, Marcus Messmer, Matthias Holdhoff, Nikhilesh R. Mazumder
Publikováno v:
Case Reports in Oncology, Vol 9, Iss 3, Pp 705-713 (2016)
Case Reports in Oncology
Case Reports in Oncology
Introduction: Ipilimumab is an immune checkpoint inhibitor targeting cytotoxic T-lymphocyte associated antigen 4 (CTLA4), approved to treat metastatic melanoma. It was the first therapy shown to prolong survival in a large, randomized clinical trial.
Autor:
RA Vierkant, LC Hartmanan, DW Visscher, Tufia C. Haddad, Ryan D. Frank, Kathy R. Brandt, Amy C. Degnim, Yaman Tarabishy, Marlene H. Frost, Ann M. Farrell, Celine M. Vachon, Ann E. McCullough, Ruth Kraft, Tina J. Hieken, Karthik Ghosh, SJ Winham, Derek C. Radisky
Publikováno v:
Cancer Research. 76:P6-10
Background Women with benign breast disease (BBD) have an increased risk for breast cancer (BC). Almost 30% of all BCs develop in women with prior BBD. Information about the features of the expected BCs after BBD would enable individualized surveilla
Autor:
Babak Banan, Yaman Tarabishy, Gundumi A. Upadhya, Pamela T. Manning, Haniee Chung, Thalachallour Mohanakumar, William C. Chapman, Jianluo Jia, Yiing Lin, Zhenyu Xiao
Publikováno v:
Surgery. 158:1642-1650
Background The susceptibility of extended criteria livers to ischemia reperfusion injury is a major obstacle in organ cold preservation. Normothermic extracorporeal liver perfusion (NELP) has been investigated to reduce ischemic damage, restore physi
Autor:
Tina J. Hieken, Ann M. Farrell, Lynn C. Hartmann, Celine M. Vachon, Daniel W. Visscher, Ruth Kraft, Amy C. Degnim, Karthik Ghosh, Yaman Tarabishy, Marlene H. Frost, Robert A. Vierkant, Derek C. Radisky, Ryan D. Frank, Tufia C. Haddad, Ann E. McCullough, Stacey J. Winham, Kathleen R. Brandt
Publikováno v:
Cancer. 122:378-385
BACKGROUND Women with benign breast disease (BBD) have an increased risk of developing breast cancer (BC). Nearly 30% of all BCs develop in women with prior BBD. Information regarding features of the expected number of BCs after BBD would enhance ind
Autor:
Jeremy Chien, R. Keira Cheetham, Yan W. Asmann, Ellen L. Goode, Jean Pierre A. Kocher, Lynn C. Hartmann, Scott H. Kaufmann, Russell J. Grocock, Julie M. Cunningham, Yaman Tarabishy, Steven N. Hart, John F. Peden, Ann L. Oberg, Ying Li, Kimberly R. Kalli, Rui Kuang, Marina Bibikova, David Bentley, Jaime I. Davila, Elizabeth J. Atkinson, Saurabh Baheti, Sabine Dietmann, Viji Shridhar, Chen Wang, Debra A. Bell, Takayo Ota, Elizabeth M. Swisher, Jian-Bing Fan, Hugues Sicotte, Sean Humphray
Publikováno v:
Nucleic acids research, vol 43, iss 14
Nucleic Acids Research
Nucleic Acids Research, vol 43, iss 14
Nucleic Acids Research
Nucleic Acids Research, vol 43, iss 14
To determine early somatic changes in high-grade serous ovarian cancer (HGSOC), we performed whole genome sequencing on a rare collection of 16 low stage HGSOCs. The majority showed extensive structural alterations (one had an ultramutated profile),
Autor:
Yaman Tarabishy, Richard J. Santen, Daniel W. Visscher, Lorelle L. Benetti, Robert A. Vierkant, Derek C. Radisky, Amy C. Degnim, Marlene H. Frost, Karthik Ghosh, Lynn C. Hartmann
Publikováno v:
Cancer Prevention Research. 7:211-217
Atypical hyperplasia is a high-risk premalignant lesion of the breast, but its biology is poorly understood. Many believe that atypical ductal hyperplasia (ADH) is a direct precursor for low-grade ductal breast cancer, whereas atypical lobular hyperp